25.10.2013 Views

Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

temperature range (90.0 to 100.0<br />

F). The collector does not take the<br />

employee’s body temperature, but<br />

immediately requires another<br />

collection under direct observation.<br />

The collector observes conduct or<br />

materials that clearly indicates an<br />

attempt to substitute or adulterate the<br />

sample (e.g., substitutes urine in<br />

plain view, blue dye in specimen<br />

presented, etc.).<br />

In the following circumstances the MRO<br />

will direct the employer to have the<br />

employee immediately retested under direct<br />

observation. The employer is required to<br />

comply with the MRO’s request.<br />

The laboratory reported to the MRO<br />

that a specimen was invalid, and the<br />

MRO determined that there was not<br />

an adequate medical explanation for<br />

the result; or<br />

The MRO had to cancel a test when<br />

the primary specimen was verified as<br />

positive, adulterated, or substituted<br />

because the split specimen was<br />

unavailable for testing (i.e., the split<br />

specimen leaked, was lost, or<br />

inadvertently discarded).<br />

In the following circumstance, the<br />

employer must authorize an observed<br />

collection:<br />

The employee has previously been<br />

determined to have used a controlled<br />

substance without medical<br />

authorization and the particular test<br />

is being conducted under the FTA<br />

regulation as a return-to-duty or<br />

follow-up test.<br />

Previously, employers were allowed to<br />

conduct observed collections for tests<br />

following a previous dilute specimen. As of<br />

August 1, 2001, this practice was prohibited.<br />

Observed collections must be performed<br />

with no advance notice to the employee.<br />

The direct observation must be conducted by<br />

a person of the same gender as the employee<br />

being tested. The same gender requirement<br />

also applies to medical professionals who<br />

are observers. The observer can be a<br />

different person from the collector and is not<br />

required to have any special training or<br />

certifications. The observer must follow the<br />

verbal instructions of the collector. The<br />

reason for the direct observation must be<br />

explained to the employee. The observer<br />

must directly watch the urine stream go<br />

from the employee’s body to the collection<br />

container.<br />

Dilute Specimens. A dilute specimen is<br />

a specimen with creatinine and specific<br />

gravity values that are lower than expected<br />

for human urine. If the test is reported as a<br />

dilute positive, the test should be treated as a<br />

verified positive test result. If the test is<br />

reported as a negative dilute, the employer<br />

may, but is not required to direct the<br />

employee to take another test. The retest<br />

must not be conducted under direct<br />

observation. Whatever the employer’s<br />

policy in this regard, all employees must be<br />

treated the same for this purpose and must<br />

be informed in advance of the retest policy.<br />

If the employer requires a retest following a<br />

negative dilute test result, the retest must be<br />

conducted with no advance notice. The<br />

result of the second test becomes the test of<br />

record and there is no opportunity for a third<br />

test, even if the second is also dilute.<br />

Section 3. LABORATORY<br />

TESTING<br />

The scientific techniques used in drug<br />

testing are virtually error-free when properly<br />

applied. The combination of immunoassay<br />

screening with confirmation by gas<br />

chromatography/mass spectrometry<br />

(GC/MS) makes the possibility of error<br />

Chapter 7. Drug Testing Procedures 7-13 August 2002

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!